Results 151 to 160 of about 7,363,707 (395)

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

A Survey of UAV Visible-Light Object Detection Based on Deep Learning [PDF]

open access: yesHangkong bingqi
With the rapid development of artificial intelligence, visible-light object detection, as an important part of computer vision technology, has been widely used in the unmanned aerial vehicle (UAV) reconnaissance field.
Liu Keshun, Zuo Xiaotong, Zhang Yuhua, Wang Changlong, Yang Sen
doaj   +1 more source

Metamorphic Testing for Object Detection Systems [PDF]

open access: yesarXiv, 2019
Recent advances in deep neural networks (DNNs) have led to object detectors that can rapidly process pictures or videos, and recognize the objects that they contain. Despite the promising progress by industrial manufacturers such as Amazon and Google in commercializing deep learning-based object detection as a standard computer vision service, object ...
arxiv  

Interactive Object Detection

open access: yes, 2019
Technical Report / Hochschule Bonn-Rhein-Sieg University of Applied Sciences.
openaire   +2 more sources

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

open access: yesMolecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen   +13 more
wiley   +1 more source

Object-Fabrication Targeted Attack for Object Detection

open access: yesNeurocomputing
Recent studies have demonstrated that object detection networks are usually vulnerable to adversarial examples. Generally, adversarial attacks for object detection can be categorized into targeted and untargeted attacks. Compared with untargeted attacks, targeted attacks present greater challenges and all existing targeted attack methods launch the ...
Xuchong Zhang   +3 more
openaire   +2 more sources

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Visual Concept Detection and Real Time Object Detection [PDF]

open access: yesarXiv, 2011
Bag-of-words model is implemented and tried on 10-class visual concept detection problem. The experimental results show that "DURF+ERT+SVM" outperforms "SIFT+ERT+SVM" both in detection performance and computation efficiency. Besides, combining DURF and SIFT results in even better detection performance.
arxiv  

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy